| Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis JW Langston, P Ballard, JW Tetrud, I Irwin Science 219 (4587), 979-980, 1983 | 6261 | 1983 |
| Rotenone, paraquat, and Parkinson’s disease CM Tanner, F Kamel, GW Ross, JA Hoppin, SM Goldman, M Korell, ... Environmental health perspectives 119 (6), 866-872, 2011 | 1647 | 2011 |
| Parkinson disease in twins: an etiologic study CM Tanner, R Ottman, SM Goldman, J Ellenberg, P Chan, R Mayeux, ... Jama 281 (4), 341-346, 1999 | 1301 | 1999 |
| Core assessment program for intracerebral transplantations (CAPIT) JW Langston, H Widner, CG Goetz, D Brooks, S Fahn, T Freeman, ... Movement disorders: official journal of the Movement Disorder Society 7 (1 …, 1992 | 1222 | 1992 |
| Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine exposure JW Langston, LS Forno, J Tetrud, AG Reeves, JA Kaplan, D Karluk Annals of Neurology: Official Journal of the american neurological …, 1999 | 1215 | 1999 |
| Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyrine (MPTP) in the squirrel monkey JW Langston, LS Forno, CS Rebert, I Irwin Brain research 292 (2), 390-394, 1984 | 1118 | 1984 |
| Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat AL McCormack, M Thiruchelvam, AB Manning-Bog, C Thiffault, ... Neurobiology of disease 10 (2), 119-127, 2002 | 1046 | 2002 |
| Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy JA Obeso, M Stamelou, CG Goetz, W Poewe, AE Lang, D Weintraub, ... Movement disorders 32 (9), 1264-1310, 2017 | 879 | 2017 |
| Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications M Farrer, J Kachergus, L Forno, S Lincoln, DS Wang, M Hulihan, ... Annals of Neurology: Official Journal of the American Neurological …, 2004 | 869 | 2004 |
| Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP) Seven cases PA Ballard, JW Tetrud, JW Langston Neurology 35 (7), 949-949, 1985 | 846 | 1985 |
| The Neurobehavioral Cognitive Status Examination: A brief but differentiated approach to cognitive assessment RJ Kiernan, J Mueller, JW Langston, C Van Dyke Annals of internal medicine 107 (4), 481-485, 1987 | 830 | 1987 |
| The effect of deprenyl (selegiline) on the natural history of Parkinson's disease JW Tetrud, JW Langston Science 245 (4917), 519-522, 1989 | 802 | 1989 |
| The Parkinson's complex: parkinsonism is just the tip of the iceberg JW Langston Annals of Neurology: Official Journal of the American Neurological …, 2006 | 776 | 2006 |
| Pargyline prevents MPTP-induced parkinsonism in primates JW Langston, I Irwin, EB Langston, LS Forno Science 225 (4669), 1480-1482, 1984 | 719 | 1984 |
| Aetiology of Parkinson's disease DB Calne, JW Langston The Lancet 322 (8365-8366), 1457-1459, 1983 | 677 | 1983 |
| Lewy bodies and parkinsonism in families with parkin mutations M Farrer, P Chan, R Chen, L Tan, S Lincoln, D Hernandez, L Forno, ... Annals of Neurology: Official Journal of the American Neurological …, 2001 | 619 | 2001 |
| Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease CB Do, JY Tung, E Dorfman, AK Kiefer, EM Drabant, U Francke, ... PLoS genetics 7 (6), e1002141, 2011 | 611 | 2011 |
| Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-l, 2, 3, 6-tetrahydropyridine (MPTP) H Widner, J Tetrud, S Rehncrona, B Snow, P Brundin, B Gustavii, ... New England Journal of Medicine 327 (22), 1556-1563, 1992 | 610 | 1992 |
| Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours LM Lasko, CG Jakob, RP Edalji, W Qiu, D Montgomery, EL Digiammarino, ... Nature 550 (7674), 128-132, 2017 | 596 | 2017 |
| Parkinson's disease in a chemist working with l-methyl-4-phenyl-l, 2, 5, 6-tetrahydropyridine. JW Langston, PAJ Ballard | 575 | 1983 |
